Global Genes has
partnered with SWAN USA to provide Undiagnosed Rare Disease
Patients an opportunity for Free Whole Exome Sequencing.
Global Genes Undiagnosed
Patient Program started from their first fundraising appeal
at their Second Annual Tribute to Champions of Hope on
September 21, 2013. Soon after they put together an advisory
board to help move this program forward. SWAN USA's founder
and president, Amy Clugston is part of the advisory board.
Patients will be selected
from SWAN USA's members who are in need of exome sequencing
to further their process in finding a diagnosis. Patients
must meet a set of criteria to be in the selection process.
Global Genes has selected
Boston-based Parabase Genomics and the UCLA
Clinical Genomics Center as the first clinical genomic
sequencing providers for the program.